Pharmafile Logo

Medius Associates

Medius provides an unrivalled range of specialised business development training solutions to cater for all levels of learning. This range extends from client specific in house tutorials through open enrolment courses to the Pharmaceutical Licensing Group’s distance learning modular MSc course.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Amiculum

AMICULUM works with the global healthcare industry to bring science to life across the product lifecycle from early opportunity assessment through to launch and beyond. By listening to the changing…

View Profile

Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop great pharmaceutical brands. We do this by creating Pharmacohesion™.

View Profile

Impetus Digital

Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education to life science companies from around the globe since 2008.

View Profile

OPEN Health

OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.

View Profile

Company Details

47 Upfield, Croydon, Surrey, CRO 5DR, UK
+44 (0)20 8654 6040

 Latest Content from PMHub 

Supporting the people who support patients

Press Releases | August 28, 2026 | Mednet

Supporting those who provide care can lead to improved experiences and health outcomes for everyone involved.

NEW PHARMA-EXCLUSIVE WEBINAR: Beyond the Hype; Practical, Compliant AI Solutions for Pharma Engagement

Press Releases | August 27, 2026 | Impetus Digital

See how top-tier pharma teams use compliant AI tools and virtual QIPs to capture real-time market intelligence, confidence scores, and audience insights from live dashboards

Intelligent Commercialization™ across the pharma lifecycle

Pharma teams are under growing pressure to navigate launch complexity, identify risks earlier, and engage HCPs more effectively.

Four steps to a smarter congress strategy: A practical guidebook

This guidebook explores how Intelligent Congress helps pharma teams create more coordinated, measurable, and impactful congress strategies.

Real Chemistry Deepens German Market Expertise with Appointment of Dirk Poschenrieder as Managing Director, Germany

Press Releases | August 25, 2026 | Real Chemistry

Senior hire strengthens Real Chemistry’s ability to help healthcare clients connect global strategy to nuanced needs for in-market execution

Cutting the friction from health comms through whole-person design

Press Releases | August 24, 2026 | Mednet

Good design can’t change the reality of illness, remove the pain, or stop the uncertainty. But it can stop learning what comes next from being another burden to carry.

The Future of Decisioning

Press Releases | August 20, 2026 | Havas Lynx

The traditional model for gathering insights is reaching a breaking point. Healthcare Professionals (HCPs) are increasingly time-poor and difficult to reach. Simultaneously, the costs of traditional market research are rising,...

Lucid Group Names Eric Muller as Chief Executive Officer to Lead Next Phase of Growth

Rick Sannem, outgoing CEO, transitions to Strategic Advisor to the Board

Treating phase 2 study design as a scientific decision is compromising launch performance, warns expert

Press Releases | August 17, 2026 | Nmblr

17th August 2026 – Treating Phase 2 study design solely as a set of scientific decisions, without commercial input, is compromising launch performance, according to Janice MacLennan, founder of Nmblr,...

Genesis Research Group Appoints Sarah Alwardt, PhD, as Executive Vice President, RWE/HEOR

Genesis Research Group today announced the appointment of Sarah Alwardt, PhD, as Executive Vice President, RWE/HEOR. She joins the Executive Leadership Team and will lead the company’s global real-world evidence...